文献速递心力衰竭与心肌病

急性心力衰竭患者的前脑啡肽、肾功能不全与预后:GREAT网络研究

Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

这项多中心研究在1908例急性心力衰竭患者中检测前脑啡肽A(PENK),发现肾功能指标是PENK水平的主要决定因素,PENK可独立预测院内肾功能恶化、院内死亡及随访期死亡,水平低于133.3 pmol/l和高于211.3 pmol/l分别识别低危和高危患者。

要点

  • PENK可独立预测急性心衰患者院内肾功能恶化(OR 1.58,95%CI 1.24-2.00,p<0.0005)。
  • PENK是1年死亡和/或心衰再住院的独立预测因子(HR 1.27,95%CI 1.10-1.45,p=0.001)。
  • PENK<133.3 pmol/l和>211.3 pmol/l分别识别低危和高危患者。

核心结论

  • PENK水平反映急性心衰的心肾状态,可预测肾功能恶化、院内死亡及随访期死亡。

研究设计与样本

  • 多中心研究,纳入1908例急性心衰患者(男性1186例,平均年龄75.66±11.74岁),检测PENK水平。

主要发现

  • 1年随访期间518例患者死亡,肾功能指标是PENK水平的主要决定因素。
  • PENK独立预测肾功能恶化(OR 1.58,95%CI 1.24-2.00,p<0.0005),模型ROC曲线下面积为0.69。
  • PENK与肾功能恶化程度相关,多变量Cox回归显示PENK是1年死亡的独立预测因子(p<0.0005)。
  • PENK是1年死亡和/或心衰再住院的独立预测因子(HR 1.27,95%CI 1.10-1.45,p=0.001)。
  • PENK可独立预测3个月或6个月结局及院内死亡,加入临床评分后主要使存活者风险降级。

关键数值与推荐

  • PENK<133.3 pmol/l识别低危患者,>211.3 pmol/l识别高危患者。
  • 院内肾功能恶化定义为5天内血浆肌酐升高≥26.5 μmol/l或较入院值升高50%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proenkephalin A (PENK) and its receptors are widely distributed. Enkephalins are cardiodepressive and difficult to measure directly. PENK is a stable surrogate analyte of labile enkephalins that is correlated inversely with renal function. Cardiorenal syndrome is common in acute heart failure (HF) and portends poor prognosis. OBJECTIVES: This study assessed the prognostic value of PENK in acute HF, by identifying levels that may be useful in clinical decisions, and evaluated its utility for predicting cardiorenal syndrome. METHODS: This multicenter study measured PENK in 1,908 patients with acute HF (1,186 male; mean age 75.66 ± 11.74 years). The primary endpoint was 1-year all-cause mortality; secondary endpoints were in-hospital mortality, all-cause mortality or HF rehospitalization within 1 year, and in-hospital worsening renal function, defined as a rise in plasma creatinine ≥26.5 μmol/l or 50% higher than the admission value within 5 days of presentation. RESULTS: During 1-year follow-up, 518 patients died. Measures of renal function were the major determinants of PENK levels. PENK independently predicted worsening renal function (odds ratio: 1.58; 95% confidence interval [CI]: 1.24 to 2.00; p < 0.0005) with a model receiver-operating characteristic area of 0.69. PENK was associated with the degree of worsening renal function. Multivariable Cox regression models showed that PENK level was an independent predictor of 1-year mortality (p < 0.0005) and 1-year death and/or HF (hazard ratio: 1.27; 95% CI: 1.10 to 1.45; p = 0.001). PENK levels independently predicted outcomes at 3 or 6 months and were independent predictors of in-hospital mortality, predominantly down-classifying risk in survivors when added to clinical scores; levels <133.3 pmol/l and >211.3 pmol/l detected low-risk and high-risk patients, respectively. CONCLUSIONS: PENK levels reflect cardiorenal status in acute HF and are prognostic for worsening renal function and in-hospital mortality as well as mortality during follow-up.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ng LL, Squire IB, Jones DJL, et al. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study. J Am Coll Cardiol. 2017. PMID: 28057251. doi:10.1016/j.jacc.2016.10.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。